Liege, Belgium, 23 March 2022 -17:45 CET - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the "Transparency Law"), that it received a notification of transparency from Goldman Sachs Group, Inc., with registered offices at Corporation Trust Center, 1209 Orange Street, Wilmington, DE 19801, USA, on 18 March 2022. Goldman Sachs has notified Mithra that it has fallen below the legal 3% threshold on 14 March 2022.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Mithra Pharmaceuticals SA published this content on 23 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 March 2022 16:56:05 UTC.